Cardio Diagnostics Holdings vs Phaos Technology Holdings (cayman)
Phaos Technology Holdings (cayman) is the larger business, with $102,806 of revenue in fiscal 2026 against $14,825 for Cardio Diagnostics Holdings (6.9 times as much). Phaos Technology Holdings (cayman) grew faster (-18.2% against -57.5%). Phaos Technology Holdings (cayman) kept more of each dollar of sales as profit: a net margin of -4662.3% against -43832.5%.
| Latest fiscal year | Cardio Diagnostics HoldingsCDIO, 2025 | Phaos Technology Holdings (cayman)POAS, 2026 |
|---|---|---|
| Revenue | $14,825 | $102,806 |
| Revenue growth | -57.5% | -18.2% |
| Net income | −$6.5m | −$4.8m |
| Operating margin | -43737.5% | — |
| Net margin | -43832.5% | -4662.3% |
| Return on equity | -78.6% | — |
| Free cash flow | −$5.9m | −$8.5m |
| Cash | $0 | $598,394 |
| Total debt | $0 | $61,521 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 15 | — |
| Market value | $4.8m | $13.5m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |